Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Prof. Yu-Hsiang Lee | Nanotechnology | Best Researcher Award

Distinguished Professor | Dept. Biomedical Sciences and Engineering/National Central University | Taiwan

Dr. Yu-Hsiang Lee is a distinguished professor in the Department of Biomedical Sciences & Engineering at National Central University (NCU), Taiwan. He is renowned for his research in nanomedicine, hydrogel-based biomaterials, and mechanotransductional biology. He holds a Ph.D. in Chemical Engineering from the University of Southern California and has accumulated significant experience in academic and industry roles. His contributions to the field of biomedical engineering have positioned him as a key figure in advancing therapies for cancer and chronic wound healing.

Profile

Google Scholar

Orcid

Scopus

Strengths for the Awards

  • Expertise and Experience: Dr. Lee holds a distinguished academic and professional career in biomedical engineering and chemical engineering. His position as a Distinguished Professor and leadership roles such as Associate Dean further demonstrate his excellence in academia.
  • Innovative Research: His work on PFC nanopolymersomes and exosomes for cancer therapy is groundbreaking, especially in addressing challenges like hypoxia in cancer treatment. His research in nanomedicine, drug delivery, and biomaterials is highly innovative and practical.
  • Strong Publication Record: With 40 journals published and a significant citation index (879 citations), Dr. Lee’s research has had a meaningful impact on his field. His work is published in high-impact journals, which highlights the quality and relevance of his contributions.
  • Industry and Collaborative Engagement: Dr. Lee’s involvement with various industry partners and hospitals demonstrates the real-world applicability and potential of his research. His collaborations with both academic and industry entities, such as Somapex Inc., YU GREEN CO., and Cathay General Hospital, reflect his commitment to advancing scientific knowledge in tandem with practical applications.
  • Ongoing Research and Innovation: Dr. Lee is engaged in ongoing research that is funded by the National Science and Technology Council in Taiwan, which indicates that his work is both cutting-edge and supported by recognized national research institutions.

Education 🎓

Dr. Lee completed his B.S. in Chemical Engineering at Tunghai University (Taiwan) in 1998, followed by an M.S. and Ph.D. in Chemical Engineering from the University of Southern California (USA) in 2002 and 2006, respectively. His academic background has laid a strong foundation for his pioneering research in biomedical engineering and nanomedicine.

Experience 💼

Dr. Lee has a diverse professional background. After earning his Ph.D., he worked as a research scientist at Sierra Sciences LLC (USA) from 2006 to 2008, focusing on drug discovery. He then joined the UCLA Dental Research Institute as a postdoctoral fellow, working on biomarker discovery projects. Since 2010, Dr. Lee has held several academic positions at NCU, including Assistant Professor, Associate Professor, Professor, and most recently, Distinguished Professor in 2022. He has also served as the Associate Dean for NCU’s College of Health Sciences & Technology from 2020 to 2023.

Research Interests On Nanotechnology 🔬

Dr. Lee’s current research interests include:

  1. Nanomedicine for cancer and bacterial infection therapies.
  2. Hydrogel-based biomaterials for chronic wound healing.
  3. Photobioreactor engineering for enhanced microalgae cultivation.
  4. Mechanotransductional biology for vascular and tumor microenvironment studies.
    His interdisciplinary research merges advanced materials science with biomedical engineering to develop innovative solutions for pressing health challenges.

Award 🏆

Dr. Lee’s groundbreaking research has earned him recognition and multiple awards. He is currently nominated for the Best Researcher Award at the Forensic Scientist Awards. His innovations, particularly in the development of perfluorocarbon (PFC) nanopolymersomes, have established him as a leader in nanomedicine. These nanocarriers are particularly promising for cancer therapy, providing effective oxygen delivery and drug loading for combined therapies.

Publication 📚

  • Novel silver and nanoparticle-encapsulated growth factor co-loaded chitosan composite hydrogel with sustained antimicrobility and promoted biological properties for diabetic …
    • Authors: YH Lee, YL Hong, TL Wu
    • Year: 2021
    • Citations: 84
  • Fabrication, characterization, and biological evaluation of anti-HER2 indocyanine green-doxorubicin-encapsulated PEG-b-PLGA copolymeric nanoparticles for targeted …
    • Authors: YH Lee, DS Chang
    • Year: 2017
    • Citations: 66
  • Synthesis and biological evaluation of quercetin–zinc (II) complex for anti-cancer and anti-metastasis of human bladder cancer cells
    • Authors: YH Lee, PT Tuyet
    • Year: 2019
    • Citations: 42
  • Chitosan/PVA hetero-composite hydrogel containing antimicrobials, perfluorocarbon nanoemulsions, and growth factor-loaded nanoparticles as a multifunctional dressing for …
    • Authors: YH Lee, SJ Lin
    • Year: 2022
    • Citations: 35
  • Synthesis, characterization, and biological verification of anti-HER2 indocyanine green–doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for …
    • Authors: YH Lee, YT Ma
    • Year: 2017
    • Citations: 32
  • Anti-EGFR indocyanine green-mitomycin C-loaded perfluorocarbon double nanoemulsion: A novel nanostructure for targeted photochemotherapy of bladder cancer cells
    • Authors: YH Lee, YC Lin
    • Year: 2018
    • Citations: 24
  • Fluid shear stress induces cell cycle arrest in human urinary bladder transitional cell carcinoma through bone morphogenetic protein receptor-smad1/5 pathway
    • Authors: YH Lee, CW Lai, YC Cheng
    • Year: 2018
    • Citations: 19
  • Synthesis, characterization, and biological evaluation of anti-her2 indocyanine green-encapsulated peg-coated plga nanoparticles for targeted phototherapy of breast cancer cells
    • Authors: YH Lee, YH Lai
    • Year: 2016
    • Citations: 17
  • Reduction of oxygen inhibition effect for microalgal growth using fluoroalkylated methoxy polyethylene glycol-stabilized perfluorocarbon nano-oxygen carriers
    • Authors: YH Lee, YL Yeh
    • Year: 2015
    • Citations: 16
  • Using fluorochemical as oxygen carrier to enhance the growth of marine microalga Nannochloropsis oculata
    • Authors: YH Lee, YL Yeh, KH Lin, YC Hsu
    • Year: 2013
    • Citations: 15

Conclusion 📝

Dr. Yu-Hsiang Lee’s career has been marked by a series of groundbreaking contributions to biomedical engineering, particularly in nanomedicine and biomaterials. His work not only addresses crucial health challenges but also paves the way for new therapeutic strategies in cancer treatment and chronic wound healing. As a distinguished professor, he continues to lead innovative research that bridges science, engineering, and medicine, making significant strides toward improving patient outcomes and advancing medical technology.